146 related articles for article (PubMed ID: 38655884)
41. Clinical correlations of mutations affecting six components of the SWI/SNF complex: detailed description of 21 patients and a review of the literature.
Kosho T; Okamoto N; Ohashi H; Tsurusaki Y; Imai Y; Hibi-Ko Y; Kawame H; Homma T; Tanabe S; Kato M; Hiraki Y; Yamagata T; Yano S; Sakazume S; Ishii T; Nagai T; Ohta T; Niikawa N; Mizuno S; Kaname T; Naritomi K; Narumi Y; Wakui K; Fukushima Y; Miyatake S; Mizuguchi T; Saitsu H; Miyake N; Matsumoto N
Am J Med Genet A; 2013 Jun; 161A(6):1221-37. PubMed ID: 23637025
[TBL] [Abstract][Full Text] [Related]
42. A novel microduplication of ARID1B: Clinical, genetic, and proteomic findings.
Seabra CM; Szoko N; Erdin S; Ragavendran A; Stortchevoi A; Maciel P; Lundberg K; Schlatzer D; Smith J; Talkowski ME; Gusella JF; Natowicz MR
Am J Med Genet A; 2017 Sep; 173(9):2478-2484. PubMed ID: 28691782
[TBL] [Abstract][Full Text] [Related]
43. The spectrum of SWI/SNF mutations, ubiquitous in human cancers.
Shain AH; Pollack JR
PLoS One; 2013; 8(1):e55119. PubMed ID: 23355908
[TBL] [Abstract][Full Text] [Related]
44. Paraspeckles interact with SWI/SNF subunit ARID1B to regulate transcription and splicing.
Reddy D; Bhattacharya S; Levy M; Zhang Y; Gogol M; Li H; Florens L; Workman JL
EMBO Rep; 2023 Jan; 24(1):e55345. PubMed ID: 36354291
[TBL] [Abstract][Full Text] [Related]
45. TNPO1-mediated nuclear import of ARID1B promotes tumor growth in ARID1A-deficient gynecologic cancer.
Yang B; Chen J; Li X; Zhang X; Hu L; Jiang S; Zhang Z; Teng Y
Cancer Lett; 2021 Sep; 515():14-27. PubMed ID: 34044070
[TBL] [Abstract][Full Text] [Related]
46. Treating ARID1A mutated cancers by harnessing synthetic lethality and DNA damage response.
Mandal J; Mandal P; Wang TL; Shih IM
J Biomed Sci; 2022 Sep; 29(1):71. PubMed ID: 36123603
[TBL] [Abstract][Full Text] [Related]
47. Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer.
Cajuso T; Hänninen UA; Kondelin J; Gylfe AE; Tanskanen T; Katainen R; Pitkänen E; Ristolainen H; Kaasinen E; Taipale M; Taipale J; Böhm J; Renkonen-Sinisalo L; Mecklin JP; Järvinen H; Tuupanen S; Kilpivaara O; Vahteristo P
Int J Cancer; 2014 Aug; 135(3):611-23. PubMed ID: 24382590
[TBL] [Abstract][Full Text] [Related]
48. De novo variation in ARID1B gene causes Coffin-Siris syndrome 1 in a Chinese family with excessive early-onset high myopia.
Huang X; Li H; Yang S; Ma M; Lian Y; Wu X; Qi X; Wang X; Rong W; Sheng X
BMC Med Genomics; 2024 May; 17(1):142. PubMed ID: 38790056
[TBL] [Abstract][Full Text] [Related]
49. Acute depletion of the ARID1A subunit of SWI/SNF complexes reveals distinct pathways for activation and repression of transcription.
Blümli S; Wiechens N; Wu MY; Singh V; Gierlinski M; Schweikert G; Gilbert N; Naughton C; Sundaramoorthy R; Varghese J; Gourlay R; Soares R; Clark D; Owen-Hughes T
Cell Rep; 2021 Nov; 37(5):109943. PubMed ID: 34731603
[TBL] [Abstract][Full Text] [Related]
50. Coffin-Siris syndrome is a SWI/SNF complex disorder.
Tsurusaki Y; Okamoto N; Ohashi H; Mizuno S; Matsumoto N; Makita Y; Fukuda M; Isidor B; Perrier J; Aggarwal S; Dalal AB; Al-Kindy A; Liebelt J; Mowat D; Nakashima M; Saitsu H; Miyake N; Matsumoto N
Clin Genet; 2014 Jun; 85(6):548-54. PubMed ID: 23815551
[TBL] [Abstract][Full Text] [Related]
51. The role of ARID1B, a BAF chromatin remodeling complex subunit, in neural development and behavior.
Moffat JJ; Jung EM; Ka M; Smith AL; Jeon BT; Santen GWE; Kim WY
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():30-38. PubMed ID: 30149092
[TBL] [Abstract][Full Text] [Related]
52. The SWI/SNF complex is a mechanoregulated inhibitor of YAP and TAZ.
Chang L; Azzolin L; Di Biagio D; Zanconato F; Battilana G; Lucon Xiccato R; Aragona M; Giulitti S; Panciera T; Gandin A; Sigismondo G; Krijgsveld J; Fassan M; Brusatin G; Cordenonsi M; Piccolo S
Nature; 2018 Nov; 563(7730):265-269. PubMed ID: 30401838
[TBL] [Abstract][Full Text] [Related]
53. Loss of ARID1A Promotes Epithelial-Mesenchymal Transition and Sensitizes Pancreatic Tumors to Proteotoxic Stress.
Tomihara H; Carbone F; Perelli L; Huang JK; Soeung M; Rose JL; Robinson FS; Lissanu Deribe Y; Feng N; Takeda M; Inoue A; Poggetto ED; Deem AK; Maitra A; Msaouel P; Tannir NM; Draetta GF; Viale A; Heffernan TP; Bristow CA; Carugo A; Genovese G
Cancer Res; 2021 Jan; 81(2):332-343. PubMed ID: 33158812
[TBL] [Abstract][Full Text] [Related]
54. A comprehensive molecular study on Coffin-Siris and Nicolaides-Baraitser syndromes identifies a broad molecular and clinical spectrum converging on altered chromatin remodeling.
Wieczorek D; Bögershausen N; Beleggia F; Steiner-Haldenstätt S; Pohl E; Li Y; Milz E; Martin M; Thiele H; Altmüller J; Alanay Y; Kayserili H; Klein-Hitpass L; Böhringer S; Wollstein A; Albrecht B; Boduroglu K; Caliebe A; Chrzanowska K; Cogulu O; Cristofoli F; Czeschik JC; Devriendt K; Dotti MT; Elcioglu N; Gener B; Goecke TO; Krajewska-Walasek M; Guillén-Navarro E; Hayek J; Houge G; Kilic E; Simsek-Kiper PÖ; López-González V; Kuechler A; Lyonnet S; Mari F; Marozza A; Mathieu Dramard M; Mikat B; Morin G; Morice-Picard F; Ozkinay F; Rauch A; Renieri A; Tinschert S; Utine GE; Vilain C; Vivarelli R; Zweier C; Nürnberg P; Rahmann S; Vermeesch J; Lüdecke HJ; Zeschnigk M; Wollnik B
Hum Mol Genet; 2013 Dec; 22(25):5121-35. PubMed ID: 23906836
[TBL] [Abstract][Full Text] [Related]
55. SWI/SNF regulates a transcriptional program that induces senescence to prevent liver cancer.
Tordella L; Khan S; Hohmeyer A; Banito A; Klotz S; Raguz S; Martin N; Dhamarlingam G; Carroll T; González Meljem JM; Deswal S; Martínez-Barbera JP; García-Escudero R; Zuber J; Zender L; Gil J
Genes Dev; 2016 Oct; 30(19):2187-2198. PubMed ID: 27737960
[TBL] [Abstract][Full Text] [Related]
56. ARID1B maintains mesenchymal stem cell quiescence via inhibition of BCL11B-mediated non-canonical Activin signaling.
Zhang M; Guo T; Pei F; Feng J; Jing J; Xu J; Yamada T; Ho TV; Du J; Sehgal P; Chai Y
Nat Commun; 2024 May; 15(1):4614. PubMed ID: 38816354
[TBL] [Abstract][Full Text] [Related]
57. Targeting ARID1A mutations in cancer.
Mullen J; Kato S; Sicklick JK; Kurzrock R
Cancer Treat Rev; 2021 Nov; 100():102287. PubMed ID: 34619527
[TBL] [Abstract][Full Text] [Related]
58. ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer.
Xu G; Chhangawala S; Cocco E; Razavi P; Cai Y; Otto JE; Ferrando L; Selenica P; Ladewig E; Chan C; Da Cruz Paula A; Witkin M; Cheng Y; Park J; Serna-Tamayo C; Zhao H; Wu F; Sallaku M; Qu X; Zhao A; Collings CK; D'Avino AR; Jhaveri K; Koche R; Levine RL; Reis-Filho JS; Kadoch C; Scaltriti M; Leslie CS; Baselga J; Toska E
Nat Genet; 2020 Feb; 52(2):198-207. PubMed ID: 31932695
[TBL] [Abstract][Full Text] [Related]
59. EWS-FLI1 modulated alternative splicing of ARID1A reveals novel oncogenic function through the BAF complex.
Selvanathan SP; Graham GT; Grego AR; Baker TM; Hogg JR; Simpson M; Batish M; Crompton B; Stegmaier K; Tomazou EM; Kovar H; Üren A; Toretsky JA
Nucleic Acids Res; 2019 Oct; 47(18):9619-9636. PubMed ID: 31392992
[TBL] [Abstract][Full Text] [Related]
60. ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers.
Guan B; Wang TL; Shih IeM
Cancer Res; 2011 Nov; 71(21):6718-27. PubMed ID: 21900401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
